Gamida Cell Profit Margin

As of the most recent data (March 2024), GMDA shows a profit margin of -826.1%. That is below the Healthcare sector average of 10.58%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 10.58%. Gamida Cell is at -826.1%, which is lower that average. That is roughly 7907.8% below the sector mean. Use the comparison chart on this page to see how GMDA stacks up against individual peers as well.

Check the historical chart to see whether GMDA's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Gamida Cell with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Gamida Cell's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -826.1%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 10.58%, while GMDA is at -826.1%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.